Which clinical feature best distinguishes lidocaine toxicity from bupivacaine toxicity in a patient who received an accidental intravascular injection during regional anesthesia?

Explanation

## Distinguishing Features of Lidocaine vs Bupivacaine Toxicity **Key Point:** Bupivacaine toxicity is characterized by profound **cardiovascular collapse with refractory ventricular fibrillation**, whereas lidocaine toxicity presents predominantly with CNS manifestations. ### Comparison Table | Feature | Lidocaine Toxicity | Bupivacaine Toxicity | | --- | --- | --- | | **Onset** | Rapid (seconds) | Rapid but may be delayed | | **Primary target** | CNS >> Cardiac | CNS = Cardiac | | **Seizures** | Early, prominent | May occur but not dominant | | **Arrhythmias** | Bradycardia, PVCs | Refractory VF, asystole | | **Cardiovascular collapse** | Late, if at all | Early, severe, resistant to ACLS | | **Lipid rescue response** | Excellent | Excellent (may require prolonged resuscitation) | | **Cardiotoxicity mechanism** | Moderate Na^+^ channel block | Severe Na^+^ and Ca^2+^ channel block | **High-Yield:** Bupivacaine's **high lipophilicity and protein binding** (95%) make it more cardiotoxic. It causes: 1. Profound myocardial depression 2. Severe conduction delays 3. **Refractory ventricular fibrillation** — the hallmark finding 4. Resistance to standard ACLS drugs **Clinical Pearl:** A patient presenting with seizures alone followed by recovery suggests lidocaine toxicity (CNS-dominant). A patient with **sudden cardiovascular collapse, bradycardia, and VF that does not respond to defibrillation or epinephrine** suggests bupivacaine toxicity — this is the critical discriminator. **Warning:** Do not confuse "both cause seizures" with "both present the same way." Bupivacaine toxicity often **bypasses the seizure phase** and goes straight to cardiovascular collapse. ### Management Implication Bupivacaine toxicity requires: - **Prolonged resuscitation** (30+ minutes) - **20% lipid emulsion bolus** (1.5 mL/kg IV) - **Repeat boluses** every 5 minutes - **Avoid vasopressin, calcium channel blockers, propofol, and local anesthetics** [cite:Butterworth 4th ed, Regional Anesthesia Ch 10]